Medical Marijuana

Louis Del Favero Orchids' latest lawsuit follows a September ruling by the 1st District Court of Appeal that sided with the Department of Health and upheld a lower court’s dismissal of a case filed by the company.

Green Thumb Industries announced it will open marijuana dispensaries in spaces adjacent to some Circle K locations starting next year.

The state Department of Health issued an “intent to approve” for Terry Donnell Gwinn, who vied with 11 others for the opportunity to join the growing medical marijuana industry.

The caps came nearly six years after voters approved a constitutional amendment broadly legalizing medical marijuana and more than three years after the Legislature authorized smokable marijuana.

A proposed amendment has been filed with the state's Division of Elections in an effort to get it placed on the 2024 ballot.

The FDA has approved a cannabis-derived drug to treat some forms of epilepsy. Now people who have other forms of the condition are using over-the-counter products, but doctors and patients worry about the unbridled world of CBD, in which product ingredients can be a mystery.

Online companies are connecting patients and doctors, and sharing fees with the physicians, which could run afoul of a law prohibiting patient brokering. The activities are drawing the ire of doctors following the rules.

Louis Del Favero Orchids sought a license under a 2017 law that granted a reference to applicants that own citrus-processing facilities. The firm paid $775,000 to buy a facility to try to help its position.

A dozen applicants are vying for a potentially lucrative license earmarked for a Black farmer who participated in decades-old litigation over discrimination in lending practices by the federal government.

A study led by Florida Gulf Coast University, Releaf App and CannaMD hopes to further clarify just what ratios of cannabinoids best reduce anxiety symptoms.

The Florida Department of Health last year began moving forward with rules to award the license and scheduled an application period in March.

For some seniors, it’s like a miracle drug that reduces pain or helps them sleep. But medical experts are concerned the stuff they buy at dispensaries has not been studied and approved like other medicines.